Thymosin α1 application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice

Cancer Letters

Volumn 159, Issue 1, 2000, Pages 9-13

  Beuth, J ^a   Schierholz, J M ^a   Mayer, Gerd ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Strathmann AG   (Germany)

Author keywords

Antimetastatic antitumor activity; BALB c mice; Immunomodulation; Thymosin 1

Indexed keywords

THYMOSIN ALPHA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; IMMUNOMODULATION; LEUKOCYTE DIFFERENTIAL COUNT; LIVER METASTASIS; LUNG METASTASIS; LYMPHOSARCOMA; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SARCOMA CELL; THYMOCYTE; THYMUS; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 0034676241     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00510-3     Document Type: Article

References (24)

1. R.A Good A.P Dalmasso G Martinez O.K Archer J.C Pierce B.W Papermaster The role of the thymus in development of immunological capacity in rabbits and mice J. Exp. Med. 116 1962 773 812
2. E.A Robey B.J Fowlkes Selective events in T-cell development Annu. Rev. Immunol. 12 1994 675 712
3. J.W Hadden Thymic endocrinology Int. J. Immunopharmacol. 14 1992 345 352
4. H.O Besedovsky A Del Rey Immune–neuro-endocrine interactions. Facts and hypothesis Endocrine Rev. 17 1966 64 81
5. M Dardenne W Savino Control of thymus physiology by peptide hormones and neuropeptides Immunol. Today 15 1994 518 523
6. R.S Schulhof T.K.L Low G.B Thurman A.L Goldstein Thymosin and other hormones of the thymus gland K Sell The Lymphocyte 1981 Alain R. Liss New York 191 202
7. A.L Goldstein F.D Slater A White Preparation, assay and partial purification of thymic lymphopoetic factor (thymosin) Proc. Natl. Acad. Sci. USA 56 1966 1010
8. 4 H.R Maurer A.L Goldstein E.D Hager Thymic Peptides in Preclinical and Clinical Medicine 1997 W. Zuckschwerdt Verlag Munich 13 27
9. 1 from calf thymus J. Biol. Chem. 254 1979 981 986
10. 1 from thymosin fraction 5 by reversed phase high performance liquid chromatography J. Liquid Chromatogr. 12 1989 845 849
11. 1 from thymosin fraction 5 of different species by high performance liquid chromatography J. Chromatogr. 266 1983 533 544
12. K Hirokawa J.E McClure A.L Goldstein Age-related changes in localization of thymosin in human thymus Thymus 4 1982 19 29
13. T.L Low A.L Goldstein Thymosins: structure, function and therapeutic applications Thymus 6 1984 27 42
14. S.A Serrate R.S Schulof L Leondaridis A.L Goldstein M.B Sztein Modulation of human natural killer cell cytotoxic activity lymphokin production, and interleukin-2 receptor expression by thymic hormones J. Immunol. 139 1987 2338 2348
15. 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes Int. J. Immunopharmacol. 12 1990 19 29
16. 1 on mouse thymocytes Cell Immunol. 9 1985 289 293
17. S.S Joshi J.G Sharp K.W Brunson Differential growth characteristics of low and high metastatic RAW 117 murine lymphosarcoma cells Oncology 44 1987 180 185
18. J Beuth H.L Ko H.-J Gabius G Pulverer Influence of treatment with immunomodulatory effective dose of β-galactoside specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental models In vivo 5 1991 29 32
19. J Beuth H.L Ko L Tunggal M.K Steuer J Geisel J Jeljaszewicz G Pulverer Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1 In vivo 7 1993 407 410
20. J Beuth J.M Schierholz G Mayer Immunomodulating and antimetastatic activity of thymic peptides in BALB/c-mice Anticancer Res. 19 1999 2993 2995
21. A.L Goldstein Clinical applications of thymosin alpha-1 Cancer Invest. 12 1994 545 547
22. D.W Wara A.L Goldstein H.E Doyle Thymosin activity in patients with cellular immunodeficiency N. Engl. J. Med. 292 1975 70 74
23. 1 Hepatology 12 1990 880 889
24. J Beuth H.L Ko L Tunggal G Buss J Jeljaszewicz M.K Steuer G Pulverer Immunaktive wirkung von mistellektin-1 in abhängigkeit von der dosierung Arzneim.-Forsch. Drug Res. 44 1994 1255 1258